MARKET WIRE NEWS

TILT Sets First Quarter 2025 Conference Call for May 15 at 5:00 p.m. ET

MWN-AI** Summary

TILT Holdings Inc. (CBOE CA:TILT, OTCPK: TLLTF), a prominent player in the cannabis industry, has scheduled its first quarter 2025 conference call for May 15, 2025, at 5:00 p.m. ET. This call aims to provide insights into the company's business strategy and financial performance for the quarter ending March 31, 2025. Ahead of the call, a press release detailing the company's financial results will be issued.

The call will feature TILT's management team, who will discuss key developments and strategic initiatives, followed by a question-and-answer segment for investors and analysts. Those interested in participating are encouraged to dial in 10 minutes before the scheduled start. The toll-free number for U.S. participants is (877) 423-9813, while international callers can reach the conference at (201) 689-8573. Additionally, the conference call will be available as a webcast and can be accessed later on the investor relations section of TILT's website.

TILT Holdings operates a diverse portfolio within the cannabis sector, positioning itself as a comprehensive provider of cannabis business solutions that encompass inhalation technologies, cultivation, manufacturing, processing, brand development, and retail. The company’s flagship subsidiary, Jupiter Research LLC, is recognized as a leader in vaporization distribution, supplying cutting-edge hardware solutions to cannabis brands and retailers across North America and Europe. Furthermore, TILT is a multi-state operator with cultivation and production capabilities in three states, utilizing the Commonwealth Alternative Care and Standard Farms brands.

For more information, stakeholders are encouraged to visit TILT's website or reach out to investor relations via the provided contact details.

MWN-AI** Analysis

As TILT Holdings Inc. prepares for its first-quarter 2025 conference call on May 15, market participants should position themselves strategically to capitalize on the insights that management will provide regarding the company's performance and future outlook. TILT, a prominent player in the cannabis industry, focuses on various business solutions, including cultivation, manufacturing, and retail through its subsidiary Jupiter Research. This call will be crucial for investors looking to gauge TILT's operational effectiveness and market position.

Key areas to listen for during the conference call include updates on revenue growth, cost management, and any shifts in demand across TILT’s product segments. Given the current trends in the cannabis market, including increasing legalization and momentum in medicinal use, the company's strategic initiatives in technology and hardware could be significant catalysts for growth. Investors should closely monitor the effectiveness of TILT's operations in its multi-state footprint, particularly enhancements in its supply chain and distribution capabilities, which are essential for maintaining competitive advantage.

Furthermore, the Q&A session presents an opportunity for stakeholders to probe into the company’s response to market dynamics, regulatory challenges, and potential expansions or partnerships. Given the evolving landscape of cannabis regulations, insights into TILT’s compliance strategies could also impact investor sentiment positively.

With TILT’s current focus on execution and innovation, sectors of growth such as vaporization technology via Jupiter Research could indicate future revenue streams. As the earnings release precedes the call, it’s advisable to analyze the financial figures for any unexpected trends or underperformance.

In conclusion, active participants in TILT's stock should approach the upcoming call with an eye on operational progress, strategic direction, and market conditions to make informed investment decisions that leverage potential gains in the burgeoning cannabis sector.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: GlobeNewswire

PHOENIX, April 24, 2025 (GLOBE NEWSWIRE) -- TILT Holdings Inc . (“TILT" or the “Company”) ( CBOE CA:TILT ) ( OTCPK: TLLTF ), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced that the Company will host a conference call on Thursday, May 15, 2025 at 5:00 p.m. Eastern Time to discuss its business strategy and financial results for the first quarter ended March 31, 2025. The Company’s results will be reported in a press release prior to the call.

TILT management will host the conference call, followed by a question-and-answer period. Interested parties can join the conference call by dialing in as directed below. Please dial-in 10 minutes prior to the call.

Date: Thursday, May 15, 2025
Time: 5:00 p.m. Eastern Time
Toll-free dial-in number: (877) 423-9813
International dial-in number: (201) 689-8573
Webcast: TILT Q1 2025 Earnings Call

The conference call will also be available for replay in the investor relations section of the Company’s website at www.tiltholdings.com .

About TILT

TILT Holdings manages a diverse portfolio of companies in the cannabis industry, encompassing technology, hardware, cultivation, and production. Its core business, Jupiter Research LLC , is a wholly owned subsidiary and a global distribution leader in the vaporization segment. Jupiter is dedicated to hardware design, research, development, and distribution to support cannabis brands and retailers across the United States, Canada, South America, and the European Union. Additionally, TILT is a multi-state operator, with cultivation and production facilities in three states under the Commonwealth Alternative Care and Standard Farms brands. For more information, visit www.tiltholdings.com .

Company Contact:

Lynn Ricci, VP of Investor Relations & Corporate Communications
TILT Holdings Inc.
lricci@tiltholdings.com

Investor Relations Contact:

Sean Mansouri, CFA
Elevate IR
TILT@elevate-ir.com
720.330.2829


FAQ**

What key financial metrics can we expect TILT Holdings Inc TLLTF to highlight during the conference call on May 15, 2025, and how do they compare to previous quarters?

During the May 15, 2025 conference call, TILT Holdings Inc (TLLTF) is likely to highlight financial metrics such as revenue growth, EBITDA margins, and cash flow trends, which are expected to show improvement compared to previous quarters due to operational efficiencies and market expansion.

2. How does TILT Holdings Inc TLLTF plan to leverage its subsidiary, Jupiter Research LLC, to enhance its market position in the cannabis inhalation technology sector?

TILT Holdings Inc. plans to leverage its subsidiary, Jupiter Research LLC, by utilizing its advanced cannabis inhalation technologies and research capabilities to enhance product offerings, improve consumer experience, and strengthen market presence in the cannabis sector.

3. Can TILT Holdings Inc TLLTF provide insights on any new product developments or technological innovations they plan to announce during the earnings call?

TILT Holdings Inc (TLLTF) may provide insights on new product developments or technological innovations during the earnings call, but specific details would depend on management’s discussion and disclosures at that time.

4. What challenges and opportunities in the cannabis industry does TILT Holdings Inc TLLTF foresee impacting their business strategy moving forward, particularly in cultivation and retail?

TILT Holdings Inc. anticipates challenges from regulatory changes and competition in the cannabis industry, while seizing opportunities through strategic partnerships and expanding their cultivation and retail footprint to enhance product offerings and consumer reach.

**MWN-AI FAQ is based on asking OpenAI questions about TILT Holdings Inc (OTC: TLLTF).

TILT Holdings Inc

NASDAQ: TLLTF

TLLTF Trading

-97.14% G/L:

$0.0001 Last:

18,890 Volume:

$0.0001 Open:

mwn-app Ad 300

TLLTF Latest News

TLLTF Stock Data

$391
375,978,578
N/A
5
N/A
Pharmaceuticals
Healthcare
US
Phoenix

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App